Moneycontrol PRO
Open App

Rupee plunges by 37 paise against dollar on new COVID-19 variant worries

At the interbank foreign exchange market, the local currency opened at 74.60 and witnessed an intra-day high of 74.58 and a low of 74.92 against the US dollar in day trade.

November 26, 2021 / 04:32 PM IST
Representative image

Representative image

The rupee on November 26 plunged by 37 paise against the US dollar as investors turned cautious in view of massive selloffs in domestic equities and worries over a new variant of COVID-19.

At the interbank foreign exchange market, the local currency opened at 74.60 and witnessed an intra-day high of 74.58 and a low of 74.92 against the US dollar in day trade.

The local unit settled at 74.89 a dollar, down 37 paise over its previous close of 74.52.

The dollar index, which gauges the greenback's strength against a basket of six currencies, was trading 0.34 percent down at 96.44.

"Rupee erased all the gains of the month following risk-off moods after worries over a new variant of COVID-19 surges. Month-end dollar demand and unwinding of carry trade in global forex markets also weighed on rupee," Dilip Parmar, Research Analyst, HDFC Securities.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The rupee registered its biggest weekly fall after October 8, and closed at its weakest level since November 2, Parmar said.

A level above 75 will clear the way for 75.68, the weakest level of the year, Parmar said, adding that "now, the support has been shifted from 73.80 to 74.30".

Meanwhile, Brent crude futures, the global oil benchmark, declined 5.50 per cent to USD 77.70 per barrel.

On the domestic equity market front, the BSE Sensex ended 1,687.94 points or 2.87 percent lower at 57,107.15, while the broader NSE Nifty declined 509.80 points or 2.91 percent to 17,026.45.

Foreign institutional investors were net sellers in the capital market on Thursday as they offloaded shares worth Rs 2,300.65 crore, as per exchange data.
first published: Nov 26, 2021 04:32 pm
ISO 27001 - BSI Assurance Mark